Annual Accounts Receivable
$504.40 K
+$82.90 K+19.67%
31 December 2023
Summary:
China Pharma Holdings annual accounts receivable is currently $504.40 thousand, with the most recent change of +$82.90 thousand (+19.67%) on 31 December 2023. During the last 3 years, it has risen by +$2500.00 (+0.50%). CPHI annual accounts receivable is now -99.28% below its all-time high of $69.70 million, reached on 31 December 2011.CPHI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$333.40 K
+$78.50 K+30.80%
30 September 2024
Summary:
China Pharma Holdings quarterly accounts receivable is currently $333.40 thousand, with the most recent change of +$78.50 thousand (+30.80%) on 30 September 2024. Over the past year, it has dropped by -$34.80 thousand (-9.45%). CPHI quarterly accounts receivable is now -99.55% below its all-time high of $73.55 million, reached on 31 March 2012.CPHI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.7% | -9.4% |
| 3 y3 years | +0.5% | -25.0% |
| 5 y5 years | -45.0% | -51.9% |
CPHI Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | +19.7% | -53.3% | +30.8% |
| 5 y | 5 years | -45.0% | +19.7% | -61.0% | +30.8% |
| alltime | all time | -99.3% | >+9999.0% | -99.5% | >+9999.0% |
China Pharma Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $333.40 K(+30.8%) |
| June 2024 | - | $254.90 K(-29.0%) |
| Mar 2024 | - | $358.80 K(-28.9%) |
| Dec 2023 | $504.40 K(+19.7%) | $504.40 K(+37.0%) |
| Sept 2023 | - | $368.20 K(+33.8%) |
| June 2023 | - | $275.20 K(-49.9%) |
| Mar 2023 | - | $549.10 K(+30.3%) |
| Dec 2022 | $421.50 K(-41.0%) | $421.50 K(-5.9%) |
| Sept 2022 | - | $447.70 K(+40.5%) |
| June 2022 | - | $318.60 K(-23.9%) |
| Mar 2022 | - | $418.70 K(-41.4%) |
| Dec 2021 | $714.50 K(+42.4%) | $714.50 K(+60.8%) |
| Sept 2021 | - | $444.30 K(+8.4%) |
| June 2021 | - | $409.70 K(-24.8%) |
| Mar 2021 | - | $545.10 K(+8.6%) |
| Dec 2020 | $501.90 K(-21.0%) | $501.90 K(-6.2%) |
| Sept 2020 | - | $535.10 K(-10.2%) |
| June 2020 | - | $595.70 K(-30.3%) |
| Mar 2020 | - | $855.10 K(+34.6%) |
| Dec 2019 | $635.40 K(-30.7%) | $635.40 K(-8.4%) |
| Sept 2019 | - | $693.40 K(+2.0%) |
| June 2019 | - | $680.10 K(-19.6%) |
| Mar 2019 | - | $845.40 K(-7.8%) |
| Dec 2018 | $916.90 K(-60.0%) | $916.90 K(+15.5%) |
| Sept 2018 | - | $793.80 K(-66.5%) |
| June 2018 | - | $2.37 M(-4.3%) |
| Mar 2018 | - | $2.47 M(+7.9%) |
| Dec 2017 | $2.29 M(-42.7%) | $2.29 M(-21.2%) |
| Sept 2017 | - | $2.91 M(-7.7%) |
| June 2017 | - | $3.15 M(-14.9%) |
| Mar 2017 | - | $3.70 M(-7.4%) |
| Dec 2016 | $4.00 M(-22.7%) | $4.00 M(-0.4%) |
| Sept 2016 | - | $4.01 M(-7.7%) |
| June 2016 | - | $4.35 M(-9.3%) |
| Mar 2016 | - | $4.79 M(-7.4%) |
| Dec 2015 | $5.17 M(-62.7%) | $5.17 M(-56.1%) |
| Sept 2015 | - | $11.78 M(-31.4%) |
| June 2015 | - | $17.18 M(-8.7%) |
| Mar 2015 | - | $18.81 M(+35.8%) |
| Dec 2014 | $13.85 M | $13.85 M(-54.8%) |
| Sept 2014 | - | $30.64 M(-14.7%) |
| June 2014 | - | $35.90 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $42.34 M(-6.2%) |
| Dec 2013 | $45.15 M(-31.8%) | $45.15 M(-14.0%) |
| Sept 2013 | - | $52.52 M(-5.1%) |
| June 2013 | - | $55.36 M(-11.7%) |
| Mar 2013 | - | $62.70 M(-5.3%) |
| Dec 2012 | $66.18 M(-5.1%) | $66.18 M(-5.2%) |
| Sept 2012 | - | $69.82 M(-2.2%) |
| June 2012 | - | $71.36 M(-3.0%) |
| Mar 2012 | - | $73.55 M(+5.5%) |
| Dec 2011 | $69.70 M(+12.5%) | $69.70 M(+1.4%) |
| Sept 2011 | - | $68.72 M(+3.9%) |
| June 2011 | - | $66.14 M(+3.4%) |
| Mar 2011 | - | $63.99 M(+3.3%) |
| Dec 2010 | $61.95 M(+20.9%) | $61.95 M(+9.1%) |
| Sept 2010 | - | $56.79 M(+3.5%) |
| June 2010 | - | $54.87 M(+4.6%) |
| Mar 2010 | - | $52.47 M(+2.4%) |
| Dec 2009 | $51.24 M(+42.3%) | $51.24 M(+4.5%) |
| Sept 2009 | - | $49.02 M(+14.4%) |
| June 2009 | - | $42.85 M(+4.4%) |
| Mar 2009 | - | $41.05 M(+14.0%) |
| Dec 2008 | $36.01 M(+93.9%) | $36.01 M(+13.7%) |
| Sept 2008 | - | $31.67 M(+15.8%) |
| June 2008 | - | $27.34 M(+10.2%) |
| Mar 2008 | - | $24.80 M(+33.6%) |
| Dec 2007 | $18.57 M(+53.5%) | $18.57 M(+8.5%) |
| Sept 2007 | - | $17.12 M(+3.5%) |
| June 2007 | - | $16.54 M(+18.5%) |
| Mar 2007 | - | $13.96 M(+15.3%) |
| Dec 2006 | $12.10 M(+112.0%) | $12.10 M(+7.1%) |
| Sept 2006 | - | $11.30 M(+23.9%) |
| June 2006 | - | $9.12 M(+10.5%) |
| Mar 2006 | - | $8.25 M(+37.1%) |
| Dec 2005 | $5.71 M(>+9900.0%) | - |
| Sept 2005 | - | $6.02 M(>+9900.0%) |
| Mar 2004 | - | $3500.00(+94.4%) |
| June 2003 | $1800.00(-30.8%) | $1800.00(-94.0%) |
| Mar 2003 | - | $30.00 K(+1566.7%) |
| Dec 2002 | - | $1800.00(0.0%) |
| Sept 2002 | - | $1800.00(-30.8%) |
| June 2002 | $2600.00 | $2600.00(-87.6%) |
| Mar 2002 | - | $21.00 K(+21.4%) |
| Dec 2001 | - | $17.30 K |
FAQ
- What is China Pharma Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for China Pharma Holdings?
- What is China Pharma Holdings annual accounts receivable year-on-year change?
- What is China Pharma Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for China Pharma Holdings?
- What is China Pharma Holdings quarterly accounts receivable year-on-year change?
What is China Pharma Holdings annual accounts receivable?
The current annual accounts receivable of CPHI is $504.40 K
What is the all time high annual accounts receivable for China Pharma Holdings?
China Pharma Holdings all-time high annual accounts receivable is $69.70 M
What is China Pharma Holdings annual accounts receivable year-on-year change?
Over the past year, CPHI annual accounts receivable has changed by +$82.90 K (+19.67%)
What is China Pharma Holdings quarterly accounts receivable?
The current quarterly accounts receivable of CPHI is $333.40 K
What is the all time high quarterly accounts receivable for China Pharma Holdings?
China Pharma Holdings all-time high quarterly accounts receivable is $73.55 M
What is China Pharma Holdings quarterly accounts receivable year-on-year change?
Over the past year, CPHI quarterly accounts receivable has changed by -$34.80 K (-9.45%)